EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug–Drug Interactions of Flumatinib as Both a Victim and a Perpetrator

Muyesaier Alifu iD, Xue Chu, Xinyan Zhu iD, Wen Yao Mak, Aole Zheng, Chunyang Pan, Qingfeng He iD, Xiao Zhu, Zheng Kuai iD, Xiaoqiang Xiang iD

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-15

DOI: 10.2147/dddt.s574169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Muyesaier Alifu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University, Shanghai, People's Republic of Chin…. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Aminopyridines, Models, Biological, Benzamides. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP3AAminopyridinesModels, BiologicalBenzamidesCytochrome P-450 CYP3A InhibitorsProtein Kinase InhibitorsHumansDrug InteractionsCaco-2 CellsMicrosomes, LiverKetoconazole

Stichwörter der Autor:innen

CYP3A4 inducerCYP3A4 inhibitorPBPK modeldrug–drug interactionflumatinib

Substanzen

Cytochrome P-450 CYP3AAminopyridinesflumatinibCYP3A4 protein, humanBenzamidesCytochrome P-450 CYP3A InhibitorsProtein Kinase InhibitorsKetoconazole

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University, Shanghai, People's Republic of China.
  • Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
  • Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.

ORCID-Profile: Muyesaier Alifu, Xinyan Zhu, Qingfeng He, Zheng Kuai, Xiaoqiang Xiang

Zitieren

APA

Alifu, M., Chu, X., Zhu, X., Mak, W. Y., Zheng, A., Pan, C., He, Q., Zhu, X., Kuai, Z., & Xiang, X. (2026). Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug–Drug Interactions of Flumatinib as Both a Victim and a Perpetrator. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s574169

Vancouver

Alifu M, Chu X, Zhu X, Mak WY, Zheng A, Pan C, et al. Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug–Drug Interactions of Flumatinib as Both a Victim and a Perpetrator. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s574169

BibTeX
@article{Alifu2026,
  author = {Alifu, Muyesaier and Chu, Xue and Zhu, Xinyan and Mak, Wen Yao and Zheng, Aole and Pan, Chunyang and He, Qingfeng and Zhu, Xiao and Kuai, Zheng and Xiang, Xiaoqiang},
  title = {Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug–Drug Interactions of Flumatinib as Both a Victim and a Perpetrator},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--15},
  doi = {10.2147/dddt.s574169}
}
Kostenlos starten →